J. Scott Garland - 16 Oct 2023 Form 3 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role
Director
Signature
/s/ Shane Kovacs, Attorney-in-Fact
Issuer symbol
OLMA
Transactions as of
16 Oct 2023
Net transactions value
$0
Form type
3
Filing time
17 Oct 2023, 16:42:58 UTC
Previous filing
26 Jun 2023
Next filing
28 May 2024

No securities are beneficially owned.